You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The clinical genetics and genomics testing firm said the funding will help as it seeks to consolidate its presence in international markets.
The acquisition of GeneWorks' oligo business widens IDT's reach in the Asia-Pacific region, the company said.
CareDx's CareDx Pty subsidiary said it will pay up to $735,000 to Conexio as a percentage of revenues from products acquired in the deal.
In addition to variant detection technology, Omicia also gets technologies like data compression, which will aid diagnostics development and data storage.
The deal, completed this month with cash reserves for an undisclosed price, adds scalability and multi-omics analysis to Qiagen's bioinformatics portfolio.
Identigene sells in-home DNA paternity test collection kits, while DNA Diagnostics conducts DNA testing for various applications, such as paternity and forensics.
Thermo Fisher said the deal strengthens its portfolio for stem cell research, and it will fold MTI-GlobalStem into its life sciences solutions segment.
The company purchased Tute in a stock-based transaction that closed last month.
The diagnostics provider said it has paid $250,000 for assets comprised of promissory notes, Series A and Series B stock, and intellectual property.
The deal marks the first software-related acquisition for Agilent since the firm acquired Cartagenia last year.
The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.
According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.
The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.
In Nature this week: the largest known collection of human genetic variants, and more.